Get started
Author

William Blad

Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab
2022 · Simeng Lin, Nicholas A. Kennedy, et al. · Nature Communications · 105
PDF
Magnetic Resonance Enterography and Intestinal Ultrasound for the Assessment and Monitoring of Crohn’s Disease
2024 · Shankar Kumar, Isabelle De Kock, et al. · Journal of Crohn s and Colitis · 56
PDF
Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study
2022 · Zhigang Liu, Kaixing Le, et al. · The Lancet. Gastroenterology & hepatology · 36
Pancreatic enzyme replacement therapy in patients with pancreatic cancer: A national prospective study
2021 · P.R. Harvey, S.C. McKay, et al. · Pancreatology · 27
UK IBD Twin Registry: Concordance and Environmental Risk Factors of Twins with IBD
2021 · Hannah Gordon, William Blad, et al. · Digestive Diseases and Sciences · 16
P352 Creation of a new guideline for the monitoring of liver fibrosis in psoriatics on Methotrexate
2021 · William Blad, Timothy Churchill, et al. · Gut · 2
PDF
982 Randomised Controlled Trial of Withdrawal of Thiopurines When Switching From Intravenous to Subcutaneous Infliximab: Results of the Minimise Study
2026 · Peter M. Irving, Andrea Centritto, et al. · Gastroenterology · 1
DOP108 Randomised controlled trial of withdrawal of thiopurines in patients with IBD switching from intravenous to subcutaneous infliximab: Results of the MINIMISE study
2026 · P M Irving, A Centritto, et al. · Journal of Crohn s and Colitis · 1
PDF
O72 Re-capturing a lost population – the benefits of a nurse-delivered HCV community cirrhosis clinic
2021 · Maryam Noeman, Sehar Farooq, et al. · Gut · 1
PDF
P247 Uptake in the UK of vaccination recommendations in inflammatory bowel disease (IBD)
2012 · D. Burger, W. Blad, et al. · Journal of Crohn s and Colitis · 1
O62 Randomised controlled trial of withdrawal of thiopurines when switching from intravenous to subcutaneous infliximab: results of the MINIMISE study
2026 · Peter Irving, Andrea Centritto, et al. · Gut
PDF
982 Randomised Controlled Trial of Withdrawal of Thiopurines When Switching From Intravenous to Subcutaneous Infliximab: Results of the Minimise Study
2026 · Peter M. Irving, Andrea Centritto, et al. · Gastrointestinal Endoscopy
O61 Impact of point of care ultrasound on time to initiating advanced therapy in IBD (GUIDE-IBD): a prospective randomised controlled trial
2025 · William Blad, Jie Yeo, et al. · Gut
P114 Patients with ileo-anal J-pouch display altered, higher pouch contractility than controls as measured with motility MRI
2025 · William Blad, Alex Menys, et al. · Gut
Sa1743: MRI MOTILITY ANALYSIS OF ILEO-ANAL J-POUCH: IMPLICATIONS FOR POUCH INFLAMMATION AND PATIENT-REPORTED SYMPTOMS
2025 · Alex Menys, William Blad, et al. · Gastroenterology
P0653 Patients with ileo-anal J-Pouch display altered, higher pouch contractility than controls as measured with motility MRI
2025 · W Blad, A Menys, et al. · Journal of Crohn s and Colitis
PDF
P0391 The impact of point of care ultrasound on time to initiating advanced therapy in IBD (GUIDE-IBD): A randomised controlled trial
2025 · W Blad, J Yeo, et al. · Journal of Crohn s and Colitis
PDF
DOP130 Analysis of the circulating methylome in 155 IBD-discordant twin pairs from UK and Scandinavia highlights differential variance and association with active inflammation
2025 · J Nowak, A Noble, et al. · Journal of Crohn s and Colitis
PDF
P283 A service evaluation of intestinal ultrasound compared with MRI small bowel for investigating gastrointestinal symptoms
2023 · William Blad, Muhammad Husnain Khizar, et al. · Gut
P74 Clinical outcomes of vedolizumab withdrawal in inflammatory bowel disease for patients in histological remission
2023 · William Blad, Lisa Whitley, et al. · Gut
P808 Risk of relapse after vedolizumab withdrawal in Inflammatory Bowel Disease for patients in histological remission
2023 · W Blad, L Whitley, et al. · Journal of Crohn s and Colitis
PDF
P214 Cine MRI assessment of colonic motility in patients with ulcerative colitis associated constipation.
2023 · C Miller, S Taylor, et al. · Journal of Crohn s and Colitis
PDF
P6 Comparing IBD patient experiences between face to face and virtual appointments
2022 · Sohail Badat, David Abe, et al. · Gut
Mo1509: DISEASE LOCATION AND ACTIVITY IMPACT SERUM AND URINE AMINO ACIDS BUT NOT OXYLIPINS IN TWINS WITH INFLAMMATORY BOWEL DISEASE
2022 · Laura Martinez-Gili, Hannah Gordon, et al. · Gastroenterology
P703 Gut bacteria composition and familiality echo Inflammatory Bowel Disease type and pathological spectrum
2022 · L Martinez-Gili, H Gordon, et al. · Journal of Crohn s and Colitis
Works count: 38
Citation count: 246
H-index: 5
I10-index: 5
Year
Topic
Type